Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Boehringer Ingelheim International GmbH, Amgen Inc., AstraZeneca PLC, Roche Holding AG, Zealand Pharma A/S, Hanmi Pharmaceutical Co., Ltd., Structure Therapeutics Inc., Altimmune, Inc., United Laboratories International Holdings Limited, Entera Bio Ltd., OPKO Health, Inc., Viking Therapeutics, Inc., Twist Bioscience Corporation and others GLP-1 agonists market is segmented based on Product, Indication , Route of Administration, Distribution Channel and Region
It is important to note that while these medications can be taken long-term, there is no official requirement to take them "forever." Treatment duration should be determined collaboratively between patient and physician based on individual circumstances, treatment response, and evolving health needs
Otani, W
Under certain circumstances, the Company may be required to disclose Your Personal Data if required to do so by law or in response to valid requests by public authorities (e.g., a court or a government agency)
Available from: Kettner J, Donnelly E, Maes ML
